INS and diabetes mellitus: The Diabetes Treatment Satisfaction Questionnaire and Treatment-Related Impact Measure for Diabetes were used as specific tools to assess secondary endpoints on diabetes satisfaction and compliance in insulin-treated patients in ONWARDS 2, 5, and 6 only.